Raymond D. Magorien

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

Steven E. Nissen, E. Murat Tuzcu, Paul Schoenhagen et al. · New England Journal of Medicine · 2005 · 1.3K citations

Medicine, Cardiology, Pharmacotherapy +17

Factors influencing the one-year mortality of dilated cardiomyopathy

Donald V. Unverferth, Raymond D. Magorien, Melvin L. Moeschberger et al. · The American Journal of Cardiology · 1984 · 551 citations

Medicine, Cardiology, Internal Medicine +5

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

C V Leier, Patricia Huss, Raymond D. Magorien et al. · Circulation · 1983 · 294 citations

Pharmacy, Cardiology, Pharmacotherapy +15

Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 4 trial

Christopher P. Cannon, Carolyn H. McCabe, Daniel J. Diver et al. · Journal of the American College of Cardiology · 1994 · 180 citations · Full text

Medicine, Cardiology, Pharmacology +13

Human myocardial histologic characteristics in congestive heart failure.

Donald V. Unverferth, Julie Fetters, Barbara J. Unverferth et al. · Circulation · 1983 · 139 citations · Full text

Medicine, Cardiology, Pathology +9